BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10644040)

  • 1. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
    Sugiyama K; Chen Z; Lee YS; Kador PF
    Biochem Pharmacol; 2000 Feb; 59(4):329-36. PubMed ID: 10644040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen bonding interactions between aldose reductase complexed with NADP(H) and inhibitor tolrestat studied by molecular dynamics simulations and binding assay.
    Lee YS; Hodoscek M; Kador PF; Sugiyama K
    Chem Biol Interact; 2003 Feb; 143-144():307-16. PubMed ID: 12604217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of non-enzymatic glycation on recombinant human aldose reductase.
    Yamaoka T; Oda A; Bannai C; Itakura M; Yamashita K
    Diabetes Res Clin Pract; 1995 Mar; 27(3):165-9. PubMed ID: 7555597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldose reductase as dihydrodiol dehydrogenase. Naphthoquinone formation by rat lens aldose reductase.
    Sato S; Sugiyama K; Carper D
    Adv Exp Med Biol; 1997; 414():499-505. PubMed ID: 9059655
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular modeling studies of the binding modes of aldose reductase inhibitors at the active site of human aldose reductase.
    Lee YS; Chen Z; Kador PF
    Bioorg Med Chem; 1998 Oct; 6(10):1811-9. PubMed ID: 9839011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
    Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
    Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dynamics simulations of the structure of aldose reductase complexed with the inhibitor tolrestat.
    Rastelli G; Costantino L
    Bioorg Med Chem Lett; 1998 Mar; 8(6):641-6. PubMed ID: 9871575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid.
    Ou P; Nourooz-Zadeh J; Tritschler HJ; Wolff S
    Free Radic Res; 1996 Oct; 25(4):337-46. PubMed ID: 8889497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the reduction of 3-acetylpyridine adenine dinucleotide phosphate by benzyl alcohol catalyzed by aldose reductase.
    Griffin BW; McNatt LG
    Arch Biochem Biophys; 1986 Apr; 246(1):75-81. PubMed ID: 3083781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human kidney aldose and aldehyde reductases.
    Sato S; Kador PF
    J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does inhibition of aldose reductase contribute to the anti-inflammatory action of setipiprant?
    Ballekova J; Soltesova-Prnova M; Majekova M; Stefek M
    Physiol Res; 2017 Sep; 66(4):687-693. PubMed ID: 28406694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
    el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG
    Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
    Sato S; Sugiyama K; Lee YS; Kador PF
    Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bovine lens aldose reductase: tight binding of the pyridine coenzyme.
    Del Corso A; Barsacchi D; Giannessi M; Tozzi MG; Camici M; Houben JL; Zandomeneghi M; Mura U
    Arch Biochem Biophys; 1990 Dec; 283(2):512-8. PubMed ID: 2125822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for isolating tight-binding inhibitors of rat lens aldose reductase.
    Sun G; Ma Y; Gao X; König S; Fales HM; Kador PF
    Exp Eye Res; 2004 Dec; 79(6):919-26. PubMed ID: 15642330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human placental aldose reductase: role of Cys-298 in substrate and inhibitor binding.
    Bhatnagar A; Liu SQ; Ueno N; Chakrabarti B; Srivastava SK
    Biochim Biophys Acta; 1994 Apr; 1205(2):207-14. PubMed ID: 8155699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.